COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Canada Jetlines (Cboe CA: CJET) Enters ACMI Lease Agreement with Air Arabia Moroc
Canada Jetlines partners with Air Arabia Moroc to deploy two aircraft in Morocco for summer operations, boosting its presence in Europe. CEO Eddy Doyle emphasizes strategic significance of the deal -
COMMUNIQUÉ DE PRESSE
A Revolutionary Breakthrough in Biomedical Testing: AmeboGenesis Introduces Sustainable Amebocyte Production for LAL Testing to Detect Bacterial Contamination
AmeboGenesis™ introduces sustainable Amebocyte production technology eliminating the need for horseshoe crab blood harvesting. The innovative method promises reliable LAL source for endotoxin testing -
-
-
COMMUNIQUÉ DE PRESSE
BHG Financial Completes First Consumer-Only ABS Transaction, Closes Over $273M in ABS Notes
BHG Financial successfully closes $273.3 million ABS notes transaction, marking a milestone as its first collateralized by 100% consumer loans, with AAA ratings from Fitch Ratings Inc. and Kroll Bond Rating Agency, LLC -
COMMUNIQUÉ DE PRESSE
Galway Metals Commences Additional Metallurgical Testing at Clarence Stream High-grade Gold Project
Galway Metals Inc. announces the commencement of additional metallurgical and process studies for the high-grade gold project at Clarence Stream in New Brunswick, Canada. The work aims to advance process flowsheet definition for improved gold recovery -
COMMUNIQUÉ DE PRESSE
Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association
Theralase Technologies Inc. to present latest Study II interim clinical data on Ruvidar™-based photodynamic therapy for BCG-Unresponsive NMIBC CIS at upcoming Advisory Board meetings in Toronto and San Antonio -
COMMUNIQUÉ DE PRESSE
SRQ Resources To Participate in Renmark's Virtual Non-Deal Roadshow on March 26, 2024
SRQ Resources Inc. announces exploration plans for Lac Brulé project in Quebec, including geophysical surveys and 2024 drilling program. Dr. Marc-Antoine Audet to present findings in virtual roadshow by Renmark Financial -
COMMUNIQUÉ DE PRESSE
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Moderna's mRNA-1283 shows higher immune response than mRNA-1273.222 in Phase 3 trial. Next-generation vaccine offers longer shelf life and storage benefits, paving way for flu-COVID combo vaccine, mRNA-1083
